The Journal of Clinical Investigation is a premier venue for discoveries in basic and clinical biomedical science that will advance the practice of medicine.

  • Impact Factor: 12.784 (2016). The JCI is one of the top journals in the “Medicine, Research & Experimental” category.
  • Broad readership and scope. The JCI reaches readers across a wide range of medical disciplines and sectors. The journal publishes basic and phase I/II clinical research submissions in all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.
  • Open access. All research is available to the public for free. The JCI deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.

    • Submit your work to the JCI

    Questions about submissions under consideration?

    • For any communication with us, please reference the tracking number assigned by the JCI noted in the acknowledgment of your submission. If you do not have this information, reference the manuscript title and corresponding author’s name. Send e-mail to staff@the-jci.org or call 734-222-6050.
    • To avoid confusion regarding correspondence, inquiries, and decisions, the JCI will typically communicate only with corresponding authors of submissions.

    Editorial Board

    The journal is headed by Editor in Chief Dr. Gordon F. Tomaselli and an Editorial Board of peer scientists at Johns Hopkins University.

    History of the JCI

    The JCI was founded in 1924 and is published by the ASCI, a nonprofit honor organization of physician-scientists incorporated in 1908. See the JCI's Wikipedia entry for detailed information.

 

Advertisement